The National Agency for Food and Drug Administration and Control (NAFDAC), has disclosed the practical steps adopted by the agency to combat the menace of substandard pharmaceutical products in the open-drug market.
Prof. Mojisola Adeyeye, Director-General of NAFDAC, made this known during a recent interview.
Adeyeye noted that NAFDAC and the Pharmaceutical Council of Nigeria PCN have upscaled their activities to protect Nigerians from bad medicine.
She noted that open-drug marketers have been relocated to the Kanawa coordinated centre in Kano, but cautioned them against selling substandard products.
Read Also: Misuse Of Antibiotics Leads To Antimicrobial Resistance, NAFDAC Warns
“NAFDAC has implemented a multi-strategic mechanism to control substandard and falsified medicines, including 12 means of control.
“The agency also conducts “Clean Report Inspection Analysis” before approving drugs from countries like India and China.
“Additionally, the Port Inspectorate checks drugs at the port of entry and some are taken to the lab for testing.”
She recalled that in the past, the control of patent medicine dealers was relieved from the Pharmaceutical Council of Nigeria (PCN), leading to an influx of fake drugs into the country.
Read Also: NAFDAC Seizes N37 Million Worth of Counterfeit Cosmetics In Abuja Raids
The NAFDAC boss disclosed that patent medicine dealers and open-drug marketers took PCN to court for nearly 10 years to continue their illegal activities and removed regulations.
She said, “The matter took a turn with the intervention of a judge who ruled in favour of PCN on February 16.”
Adeyeye revealed that 180 approved products were stopped at the port from entering the country due to their substandard quality.
The NAFDAC boss warned importers of dangerous chemicals to desist, stating that the agency was working with the Office of the National Security Adviser to prevent such activities.
